Wolters Kluwer to acquire Lexi-Comp

PHILADELPHIA — Market research firm Wolters Kluwer Health will acquire drug information provider Lexi-Comp, Wolters Kluwer said Wednesday. Financial terms of the deal were not disclosed.

Wolters Kluwer already had a relationship with Lexi-Comp through the former’s UpToDate business, which provides electronic clinical information through the Internet and mobile devices to more than 400,000 clinicians and other users. Lexi-Comp, based in Cleveland, provides drug information and medical reference content to more than 1,500 hospitals around the world and publishes drug monographs on more than 1,700 products.

Wolters Kluwer said the acquisition would strengthen its position in the clinical decision support and point-of-care segments and provide customers with more robust drug information and clinical content, allowing pharmacists, nurses and physicians to use an extended suite of mobile capabilities and online platforms.

Login or Register to post a comment.